Nachrichten zur Johnson & Johnson Aktie

Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?

After hitting fresh all-time highs last week, investors are turning their attention to JNJs Q2 report, which is scheduled for…

Q2 Earnings Season Arrives: Can Results Match Upbeat Expectations?

The big banks dominate this weeks reporting docket, though several notable companies from other sectors will also report, including Netflix,…

Johnson Service backs outlook despite hospitality weakness

Johnson Service Group plc (LSE:JSG) said it remained on track to deliver its 2026 margin target despite continued weakness in…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Megatrend Folger: Johnson & Johnson erklimmt neues Allzeithoch

Zum Start in das verlängerte Feiertagswochenende in den USA rund um den 4. Juli zeigt sich an der Wall Street…

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Johnson & Johnson doesnt need GLP-1 drugs to grow, and thats good news for long-term investors.…

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gauze…

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How…

Johnson & Johnson snaps six straight sessions of gains

…

Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?

Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The…

Johnson & Johnson Aktie: Weiteres Potenzial vor den Zahlen

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Guggenheim Securities:Guggenheim-Analyst Vamil Divan habe das Kursziel für die Aktie von Johnson…

2 Blue Chip Industrial Stocks Id Buy Into This Weeks Weakness Without Hesitation

Investors looking for industrial stocks experiencing modest pullbacks might want to examine Canadian National Railway and Johnson Controls.…

J&J CEO Now Sees Line of Sight to Double-Digit Growth for His $100 Billion Company. Heres Why Investors Should Pay Attention.

Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) concluded the recent trading session at $244.88, signifying a +1.61% move from its prior days close.…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

J&J CEO sends a clear message on the obesity drug boom

Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of the decade.…

Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm

Bear markets are a part of investing life, but you can prepare for them ahead of time.…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Top Research Reports for Alphabet, Broadcom & Johnson & Johnson

Todays Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Broadcom Inc. (AVGO) and Johnson…

Johnson & Johnson auf Kurs zur 100 Mrd. USD-Umsatzmarke! Ich halte an meinen Aktien fest!

Nach der Abspaltung der Konsumgütersparte Kenvue 2023 hat sich Johnson & Johnson (i)(JNJ) erfolgreich als reines Innovationskraftwerk für Pharma und…

Johnson & Johnson to invest $1 billion in vision operations in Jacksonville

With $12 million in city incentives in hand, the company is building a distribution center in Northwest Jacksonville and upgrading…

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts

Johnson & Johnson (JNJ) closed at $240.87 in the latest trading session, marking a +1.07% move from the prior day.…

Johnson & Johnson bets $1 billion on hard-to-treat cancer

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living…

Johnson & Johnson to buy Firefly Bio for $1 billion

Johnson & Johnson said ?on Monday it will acquire ?biotech Firefly Bio for $1 billion in cash, as it ?looks…

Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock

Johnson & Johnson takes a licking, and the dividend keeps on ticking higher.…

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Johnson & Johnson (JNJ) closed at $228.17, marking a +2.21% move from the previous day.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

BEERSE, BELGIUM , June 03, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced nipocalimab met the…

Johnson & Johnson Hopes to Dethrone AbbVies Biggest Growth Driver. Heres Why Investors Shouldnt Panic

AbbVies shareholders can sleep easy.…

XOMA (XOMA) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEWednesday, March 18, 2026 at 8:00 a.m. ETCALL PARTICIPANTSChief Executive Officer — Owen HughesChief Investment Officer…

Johnson & Johnson: Diese zwei Entwicklungen könnten die Aktie antreiben

Johnson & Johnson ist einer der größten Gesundheitskonzerne der Welt und in den Bereichen Pharma, Medizintechnik sowie Gesundheitslösungen tätig. Das Unternehmen entwickelt…

TopBuild (BLD) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DateFeb. 26, 2026, 9:00 a.m. ETCall participantsChairman, President, and CEO — Robert BuckChief Operating Officer —…

Magic Johnson Says Victor Wembanyama’s Defensive Tactics ‘Won’t Work’ Against The Knicks

Magic Johnson Says Victor Wembanyama’s Defensive Tactics ‘Won’t Work’ Against The Knicks…

Johnson Outdoors Announces Cash Dividend

RACINE, Wis., May 29, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) reached $225.33 at the closing of the latest trading day, reflecting a -2.37% change compared to…

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer

Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer are benefiting from innovation, pipeline growth and strong demand in key…

HURA: Refining TBS-2025 Development Plan

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn May 15th, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Frontier IP portfolio company Dekiln to explore partnership with Johnson Tiles

Frontier IP has announced that portfolio company Dekiln has signed a Memorandum of Understanding with Johnson Tiles, one of the…

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Todays Market

Johnson & Johnson sells products that are necessities, not just nice-to-haves.…

Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $231.73, marking a +1.05% move from the previous day.…

Gunnison Copper reports Q1 profit as Johnson Camp ramp-up continues

Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) has reported a profitable first quarter as the company advanced development of its Arizona…

Top Stock Reports for Johnson & Johnson, Oracle & Netflix

Johnson & Johnson, Oracle and Netflix lead Zacks top stock reports as analysts spotlight growth drivers, cloud gains and new…

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.…

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.…

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Modular data center builder Armada raises $230 million, to build Arizona factory with new investor Johnson Controls

Modular data center builder Armada has raised $230 million from investors at a valuation of $2 billion, with BlackRock becoming…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…